Member Info for Shpunken

That’s a lot of info.. only negative is the trump factor.. apart from that, the fda update is amazing, the revenue is solid, and they’ve managed to prolong the budget to end of Q2 of 2026.. markets will only care about funding, but we are on the right path, and it looks like 5/6m will be achieved

Just one branch of a larger group, let’s see how this develops..

This is a very interesting turn of events, especially considering what amati was doing for the past 12 months.. looks like their new owners want in.. keep an eye on this development, if they keep buying it could be a sign for a new partnership for financing

Maven was established in 2009 following a management buyout of the private equity division of Aberdeen Asset Management PLC. In 2021, it became a subsidiary of Mattioli Woods plc, a leading UK wealth management and financial planning firm .

The firm typically invests between £250,000 and over £10 million, supporting businesses at various growth stages across sectors such as technology, healthcare, manufacturing, and renewable energy .

Acquisition of Maven Renovar VCT: In May 2025, Maven was appointed as the investment manager for Maven Renovar VCT (formerly Amati AIM VCT), expanding its VCT offerings

Mammoth cash burn? That’s just not accurate.. also, the final year results will be out in about 10 days, and hopefully some estimates on the revenue for the year end results.. if we hit $6/7m, happy days ahead

8th of May at 3pm BST

Neon I assume u haven’t been following the latest news.. we are making money now, and next fundraiser will definitely be above 1p.. I still think they have enough time to get a partner

Unfortunately trump has cancelled funding to many cancer funds, for kids including. And fda is in a mess, same as the whole Whitehouse.. atm I can’t see any positives.. my only hope is for a major to come and partner with us

Unfortunately it looks like fda has been hit by trump as well, they are citing severe worker shortages and have suspended various departments.. this could delay our work

They did talk about it in one of the interviews I guess will have to look through a few of them

Should be sometime this month

The cash part is of a concern, but the sales are exceeding expectations, at this rate we should hit 2026/27 numbers by the end of this year

Things are happening, and we are moving forward, unfortunately though mr market doesn’t care.. they want to see partnerships and money

It will recover quickly, and is a perfect opportunity for a quick trade.. technically this result won’t make a difference long term as long as other pay zones come good

yep, i didn’t want to start spreading rumours, but it does seem like we could be fast tracked.. my only concern is the idiot in the whitehouse that can cause a lot of damage for us. won’t surprise me if they start messing with the fda as well, as they want to have a hand in every regulatory body in the country for obvious reasons.. but i do have faith in the us institutions, they’ve withstood ******s like that before and i am sure we will be ok.. our tech can be useful in so many ways and the revenue stream can only grow bigger cause of that.. time is not on our side, but i am sure the team is working to bring in a partner. one thing no one can doubt is our tech, it will save millions of lives

New Research Identifies Cause of Pulmonary

Long COVID with Xenon MRI

"That's what hyperpolarized Xenon MRI does. It lets us see beneath the surface." — Dr. Don Sin

A groundbreaking study from the Centre for Heart Lung Innovation (HLI) at St. Paul's Hospital reveals that inflammation in the smallest airways of the lungs is the likely cause of pulmonary long COVID—detail that traditional tests like CT scans and pulmonary function tests (PFTs) have been unable to detect.

This work lays the foundation for new clinical opportunities, particularly in understanding and treating long COVID. It opens the door to personalized medicine using Xenon MRI to track disease trajectories and guide targeted therapy.

Seems like markets don’t care.. we are making over 3m in sales now, and the reaction was mute.. even if they show 6/7m nothing will change.. markets want to see a partnership with financing, it’s obv now

We don’t need funding in 2025, we will need it half way through 2026

Mike have u seen what’s happening with the majors, we are affected but not as bad as some other stocks.. this has nothing to do with the company, and therefore presents a good opportunity to buy more.. at these prices wont surprise me if we get bent over and taken over

Yep, saw that as well… unfortunately we are being murdered by an orange idiot.. I have no doubts the company will achieve its goals..